Plain-English translation of NCT07617974 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is tracking how atrial fibrillation—a common irregular heartbeat—changes the tricuspid valve, which sits on the right side of your heart. Researchers will use advanced 3D ultrasound imaging to closely observe your heart valve before and after you have a standard ablation procedure (a treatment to correct your irregular heartbeat). The goal is to understand which patients develop problems with this valve over time, so doctors can better predict and prevent complications.
Doctors know that atrial fibrillation can damage the tricuspid valve, but they don't fully understand which patients are at highest risk or how to predict who will develop serious valve problems. This study will help fill that gap by carefully tracking valve changes in people with atrial fibrillation, which could lead to better care and earlier treatment decisions.
You likely qualify if…
You likely don't qualify if…
You will have a heart ultrasound (echocardiogram) before your scheduled ablation procedure, which includes special 3D imaging of your tricuspid valve. You will also wear a portable heart monitor (Holter monitor) at baseline and at 3 months and 12 months after your procedure to track your heart rhythm. At 12 months, you will return for a follow-up heart ultrasound to see how your valve has changed. The study involves no extra medications or procedures beyond what you would normally receive for your atrial fibrillation treatment.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Italy
Sponsor
Centro Cardiologico Monzino
Collaborators
Istituto Clinico Humanitas
Enrollment target
~66 participants
Started
May 2026
Primary completion
May 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.